ERBB2 and ductal breast carcinoma in situ: Cancer epithelial cells in the invasive cancer area presumably invade other areas, resulting in an increased ERBB2 expression in all other pathologist-identified areas except the DCIS, and these invaded areas also exhibit an increase in the proportion of cancer epithelial cells (Fig. 3, H and I, and fig.